Vexos' LaGrange, Ohio Facility Receives UL Certification


Reading time ( words)

Vexos' manufacturing facility in LaGrange, Ohio, is now certified under UL Certification ZPV12. With this UL certification, and its FDA registration, the facility can build the most complex or the simplest products, under the strict processes of its rigorous quality systems.

Markets requiring final assembly UL certification have an easier time receiving their certification when working with Vexos now that its facility has UL Certification ZPV12. This traceability certification ensures these products are built to exacting standards, with full traceability, and therefore do not need individual inspection post assembly. This seamless qualification process saves valuable time and money during final inspection because UL does not need to disassemble the product for testing.

"This UL Certification is just another example of the importance of health, safety, traceability and quality for our customers.  We are proud of this team, the equipment, but especially the processes in place that provide superior products in the market," said John Wilkinson, SVP & GM of Vexos LaGrange.

Share

Print


Suggested Items

Laserssel Brings High-speed Soldering to New Application Areas

06/10/2019 | Barry Matties, I-Connect007
In this interview with I-Connect007, Denis Barbini, general manager of Laserssel, talks about the company's new laser-selective reflow solution aimed at reducing a typical reflow oven’s 10-minute cycle down to just 10 seconds as well as the overall benefits manufacturers could see from streamlining this process.

Synergy Between Smart Manufacturing and the Secure Supply Chain (Part 2)

06/05/2019 | Michael Ford, Aegis Software Corp.
With the trend of shortening lead-times within the material ordering process, and the frequency with which urgent orders for materials from the grey market are made, there is increased opportunity for the ingress of counterfeit materials. The situation is made far worse when a genuine shortage of materials in the supply chain occurs. The consequences of not being able to eliminate the risk of defects getting through into the market will be disastrous for individuals as well as for the company brand image, not to mention the associated costs of recovery. It is only a matter of time, unless something very significant changes.

The GraftWorx Fluid Management Patch Story

05/31/2019 | Anthony Flannery, GraftWorx
The GraftWorx vision is to connect patients to clinicians with clinical data that will have a meaningful impact on their care. Its first application is to monitor patients with end-stage renal disease or kidney failure using a wearable device called the SmartPatch that records numerous clinical cardiovascular metrics. This article details how GraftWorx was designed, fabricated, and assembled.



Copyright © 2019 I-Connect007. All rights reserved.